Form 8-K - Current report:
SEC Accession No. 0001213900-20-042738
Filing Date
2020-12-15
Accepted
2020-12-15 14:27:48
Documents
9
Period of Report
2020-12-15
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea131647-8k_aytubioscience.htm 8-K 39340
2 INVESTOR PRESENTATION, DATED DECEMBER 15, 2020 ea131647ex99-1aytubio.htm EX-99.1 14490
3 GRAPHIC ex99-1_001.jpg GRAPHIC 135954
4 GRAPHIC ex99-1_002.jpg GRAPHIC 252536
5 GRAPHIC ex99-1_003.jpg GRAPHIC 274274
6 GRAPHIC ex99-1_004.jpg GRAPHIC 192372
7 GRAPHIC ex99-1_005.jpg GRAPHIC 404544
8 GRAPHIC ex99-1_006.jpg GRAPHIC 543917
9 GRAPHIC ex99-1_007.jpg GRAPHIC 106419
  Complete submission text file 0001213900-20-042738.txt   2568103
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOSCIENCE, INC (Filer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38247 | Film No.: 201389239
SIC: 2834 Pharmaceutical Preparations